Establishing a multi-stakeholder Prosperity Council and setting ambitious performance targets are key to overcoming Canada’s decades long productivity and competitiveness problems, says new report.
Organization: Industry Strategy Council
The federal government needs to make it an urgent priority to provide increased and predictable funding for health and biosciences research, or risk losing the nation’s health research workforce to competing countries like the U.S., the U.K. and Australia, says Paul-Émile Cloutier, president and CEO of HealthCareCAN, in an op-ed.
Canada needs a national R&D spending target and a permanent process for building a better R&D innovation system to overcome its lagging innovation performance and fuel longterm economic growth, says David Watters, president and CEO of Global Advantage Consulting Group.
A new report by the Industry Strategy Council to assess the impact of COVID-19 on industry provides a pathway to restart, recover and reimagine Canada’s economy.
Ingrid Waldron and HealthCareCAN receive top Research Canada advocacy awards, AbCellera’s IPO nearly triples in value on first day of trading, Diversity Institute’s report on the Canadian labour market during the pandemic is out, and an international AI hub specializing in pharmaceutical R&D opens in Montreal.
Innovation Science and Economic Development Canada, in a detailed response to growing criticisms, defends the federal government’s innovation performance, policies and programs.